Phosphonate biochemistry

GP Horsman, DL Zechel - Chemical reviews, 2017 - ACS Publications
Organophosphonic acids are unique as natural products in terms of stability and mimicry.
The C–P bond that defines these compounds resists hydrolytic cleavage, while the …

Fosfomycin: mechanism and resistance

LL Silver - Cold Spring Harbor perspectives in …, 2017 - perspectivesinmedicine.cshlp.org
Fosfomycin, a natural product antibiotic, has been in use for> 20 years in Spain, Germany,
France, Japan, Brazil, and South Africa for urinary tract infections (UTIs) and other …

Coordination of bacterial cell wall and outer membrane biosynthesis

KR Hummels, SP Berry, Z Li, A Taguchi, JK Min… - Nature, 2023 - nature.com
Gram-negative bacteria surround their cytoplasmic membrane with a peptidoglycan (PG)
cell wall and an outer membrane (OM) with an outer leaflet composed of lipopolysaccharide …

[HTML][HTML] Development and clinical application of phosphorus-containing drugs

H Yu, H Yang, E Shi, W Tang - Medicine in drug discovery, 2020 - Elsevier
Phosphorus-containing drugs belong to an important class of therapeutic agents and are
widely applied in daily clinical practices. Structurally, the phosphorus-containing drugs can …

Epoxides: Developability as active pharmaceutical ingredients and biochemical probes

B Kaur, P Singh - Bioorganic Chemistry, 2022 - Elsevier
Epoxide functional group is a part of several natural as well as synthetic compounds.
Irrespective of the role of epoxide group in drug efficacy and the use of epoxide compounds …

New antibiotics from Nature's chemical inventory

TA Wencewicz - Bioorganic & medicinal chemistry, 2016 - Elsevier
The doom and gloom of antibiotic resistance dominates public perception of this drug class.
Many believe the world has entered the post-antibiotic era. Classic and modern approaches …

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China

Y Li, B Zheng, Y Li, S Zhu, F Xue, J Liu - PloS one, 2015 - journals.plos.org
Escherichia coli is one of the most common pathogens in nosocomial and community-
acquired infections in humans. Fosfomycin is a broad-spectrum antibiotic which inhibits …

Deep mutational scanning of essential bacterial proteins can guide antibiotic development

L Dewachter, AN Brooks, K Noon, C Cialek… - nature …, 2023 - nature.com
Deep mutational scanning is a powerful approach to investigate a wide variety of research
questions including protein function and stability. Here, we perform deep mutational …

CTX-M-Producing Escherichia Coli Strains: Resistance To Temocillin, Fosfomycin, Nitrofurantoin And Biofilm Formation

A Giedraitiene, L Pereckaite… - Future …, 2022 - Taylor & Francis
Aim: ESBL-producing and bacterial biofilms-forming Escherichia coli are associated with
antimicrobial treatment failure. This study aimed to investigate the phenotypic resistance …

Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development

GL Moraes, GC Gomes, PRM De Sousa, CN Alves… - Tuberculosis, 2015 - Elsevier
Tuberculosis (TB) is the second leading cause of human mortality from infectious diseases
worldwide. The WHO reported 1.3 million deaths and 8.6 million new cases of TB in 2012 …